Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sutykine 50mg Capsule

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Sunitinib (50mg)

Overview Sutykine 50mg Capsule

Oncaspar (50mg capsules) is a medication employed in the management of renal cell carcinoma and gastrointestinal stromal tumors. Its mechanism involves inhibiting specific enzymes crucial for cancer cell proliferation, thereby reducing tumor size and slowing its advancement. Oncaspar can be administered with or without food, but consistent daily timing optimizes therapeutic effects. Dosage and frequency are determined by your physician, based on your specific condition and may be adjusted. Adhere strictly to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse reactions. Benefits may not be apparent for weeks or months; discontinue only under medical guidance. Common side effects include fatigue, loose stools, nausea, vomiting, altered taste perception, and reduced appetite. Regular monitoring of blood pressure and thyroid function is often recommended. Oncaspar can lower blood glucose, potentially causing hypoglycemic episodes (including fainting); diabetics should monitor their blood sugar levels closely and discuss potential adjustments to anti-diabetic medications with their doctor. Prior to commencing treatment, inform your physician of any pre-existing heart, liver, kidney disease, or bleeding disorders. Interactions with other medications are possible; disclose all current medications to your healthcare provider. This medication is contraindicated during pregnancy and lactation. Reliable contraception is essential for both partners throughout the treatment period to prevent conception.

Primary Ingredients of Sutykine 50mg Capsule

No text provided. Please provide the text you wish me to rephrase.

Uses of Sutykine 50mg Capsule

Managing renal cell carcinoma and gastrointestinal stromal tumors

Major Benefits of Sutykine 50mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 50mg Capsules. These capsules can be administered with or without food, though consistent timing is recommended.

Common Side effects of Sutykine 50mg Capsule:

  • Hand-foot syndrome
  • Bleeding disorder
  • Low blood platelets
  • Decreased appetite
  • Nausea
  • Vomiting
  • Weakness
  • Abdominal pain
  • Indigestion
  • High blood pressure
  • Diarrhea
  • Stomatitis (Inflammation of the mouth)
  • Taste change

How to use Sutykine 50mg Capsule:

Follow your doctor's instructions precisely regarding dosage and treatment length for Sutykine 50mg Capsules. These capsules can be ingested with or without food, although consistent timing is recommended.

How Sutykine 50mg Capsule works:

Sutykine 50mg capsules are an anticancer agent. Their mechanism of action involves targeted inhibition of tyrosine kinase, a cell surface protein crucial for cancer cell proliferation. This medication also suppresses angiogenesis, the formation of new blood vessels that nourish tumors, thus hindering malignant growth.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

The safety of consuming alcohol while taking a 50mg Sutykine capsule is undetermined. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sutykine 50mg Capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sutykine 50mg capsules while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Taking Sutykine 50mg Capsules might lead to adverse reactions that impair driving ability. Dizziness is a possible side effect of this medication. Refrain from driving or operating equipment should dizziness occur during treatment.

KidneyKidneySAFE IF PRESCRIBED

Sutykine 50mg capsules can be administered to patients with kidney impairment without modification of the prescribed dosage.

LiverLiverSAFE IF PRESCRIBED

Sutykine 50mg capsules can be administered to patients with hepatic impairment without modification of the prescribed dosage.

What if you forget to take Sutykine 50mg Capsule :

Omit any missed Sutykine 50mg Capsule dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sutykine 50mg Capsule

LabelValue
Chemical Category Indole and Pyrrole Compounds
Developing Habits No.
Treatment Category Cancer Therapeutics

FAQs on Sutykine 50mg Capsule

Follow your doctor's instructions precisely when taking Sutykine 50mg Capsules. This medication should be initiated only by physicians experienced in cancer treatment. Take one capsule daily, with or without food. Avoid grapefruit juice and grapefruit during treatment to minimize potential side effects.
Sutykine 50mg Capsules may cause skin lightening and hair loss. You might also experience dry, thickened, or cracked skin, blisters, or rashes on your palms and soles. These side effects usually disappear after stopping the medication. However, serious, potentially fatal skin reactions like severe rash or rapidly spreading skin ulcers are possible. Report any signs of infection near a skin injury (fever, pain, redness, swelling, pus, or blood drainage) to your doctor immediately.
Sutykine 50mg Capsules can cause life-threatening liver damage. Report itching, yellowing of eyes or skin, dark urine, or right upper abdominal pain or discomfort immediately. Your doctor will monitor your liver function with blood tests before and during treatment. Treatment with Sutykine 50mg Capsules may be temporarily or permanently discontinued if liver problems develop.
Sutykine 50mg Capsules have no generic equivalents. They function by inhibiting protein kinase, an enzyme on the surface of cancer cells that drives their growth and spread. This inhibition prevents cancer progression. Other protein kinase inhibitors include erlotinib, gefitinib, lapatinib, vemurafenib, and dasatinib.
Sutykine 50mg Capsules haven't been studied with other chemotherapy drugs. Its use in gastrointestinal stromal tumors (GIST), a cancer affecting the stomach and intestines, is specifically for patients whose imatinib treatment has failed or is unsuitable.
Sutykine 50mg Capsules can lower blood sugar. Diabetic patients should monitor their blood sugar closely as it could drop dangerously low, potentially causing unconsciousness. Your anti-diabetic medication dosage may require adjustment based on these readings.
Sutykine 50mg Capsules may raise blood pressure. Regular blood pressure monitoring is crucial. Report severe headaches, dizziness, lightheadedness, or vision changes to your doctor immediately. They may adjust your medication or temporarily suspend treatment to manage blood pressure.
Sutykine 50mg Capsule
52,708
MRP 61,004
13% off